Skip to main content

Harnessing RNAi: Alnylam’s path from lab discovery to life-changing treatments

By SciTech Daily  
   May 24, 2024

Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has developed five FDA-approved RNAi medicines, significantly impacting patient lives. The company continues to innovate in RNAi delivery, aiming to treat various diseases, including neurological disorders

Full story

Get the latest on healthcare leadership in your inbox.